换一批
换一批A simplified interventional mapping system (SIMS) for the selection of combinations of targeted treatments in non-small cell lung cancer.
作者：
Vladimir,Lazar [1]
;
Eitan,Rubin [2]
;
Stephane,Depil [3]
;
Yudi,Pawitan [4]
;
Jean-François,Martini [5]
;
Jesus,Gomez-Navarro [6]
;
Antoine,Yver [7]
;
Zhengyin,Kan [8]
;
Jonathan R,Dry [9]
;
Jeanne,Kehren [10]
;
Pierre,Validire [11]
;
Jordi,Rodon [6]
;
Philippe,Vielh [7]
;
Michel,Ducreux [9]
;
Susan,Galbraith [10]
;
Manfred,Lehnert [11]
;
Amir,Onn [12]
;
Raanan,Berger [13]
;
Marco A,Pierotti [14]
;
Angel,Porgador [1]
;
C S,Pramesh [1]
;
Ding-wei,Ye [15]
;
Andre L,Carvalho [9]
;
Gerald,Batist [10]
;
Thierry,Le Chevalier [11]
;
Philippe,Morice [8]
;
Benjamin,Besse [16]
;
Gilles,Vassal [16]
;
Andrew,Mortlock [17]
;
Johan,Hansson [3]
;
Ioana,Berindan-Neagoe [18]
;
Robert,Dann [19]
;
Joel,Haspel [20]
;
Alexandru,Irimie [21]
;
Steve,Laderman [1]
;
Hovav,Nechushtan [1]
;
Amal S,Al Omari [1]
;
Trent,Haywood [1]
;
Catherine,Bresson [9]
;
Khee Chee,Soo [10]
;
Iman,Osman [11]
;
Hilario,Mata [5]
;
Jack J,Lee [22]
;
Komal,Jhaveri [23]
;
Guillaume,Meurice [24]
;
Gary,Palmer [25]
;
Ludovic,Lacroix [22]
;
Serge,Koscielny [23]
;
Karina Agda,Eterovic [26]
;
Jean-Yves,Blay [27]
;
Richard,Buller [28]
;
Alexander,Eggermont [29]
;
Richard L,Schilsky [2]
;
John,Mendelsohn [30]
;
Jean-Charles,Soria [31]
;
Mace,Rothenberg [32]
;
Jean-Yves,Scoazec [32]
;
Waun Ki,Hong [31]
;
Razelle,Kurzrock [1]
作者单位：
Gustave-Roussy Cancer Center, Villejuif, France.
[1]
WIN Consortium, Villejuif, France.
[2]
Ben-Gurion University of the Negev, Beer-Sheva, Israel.
[3]
Leon Berard Cancer Center, Lyon, France.
[4]
Karolinska Institutet, Stockholm, Sweden.
[5]
Pfizer Oncology Research, San Diego, CA, USA.
[6]
Pfizer Oncology, Pfizer Inc, New York, NY, USA.
[7]
Takeda Pharmaceuticals International Co., Cambridge, MA, USA.
[8]
AstraZeneca Pharmaceuticals LP, Global Medicines Development, Gaithersburg, MD, USA.
[9]
Oncology iMED, Waltham, MA, USA.
[10]
Oncology iMED, Macclesfield, Cheshire, UK.
[11]
Sanofi, Paris, France.
[12]
Institut Mutualiste Montsouris, Paris, France.
[13]
Vall d'Hebron Institute of Oncology Universitat Autonoma de Barcelona, Barcelona, Spain.
[14]
University Paris-Sud, Kremlin-Bicetre, France.
[15]
Chaim Sheba Medical Center, Tel-Hashomer, Israel.
[16]
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.
[17]
Tata Memorial Centre, Mumbai, India.
[18]
Fudan University Shanghai Cancer Center, Shanghai, China.
[19]
Fundacao Pio XII - Barretos Cancer Hospital, Barretos, Brazil.
[20]
Segal Cancer Centre at the Jewish General Hospital, McGill University, Montreal, QC, Canada.
[21]
University of Medicine and Pharmacy Iuliu Hatieganu, Cluj-Napoca, Romania.
[22]
Ion Chiricuta Oncology Institut, Cluj-Napoca, Romania.
[23]
General Electric Healthcare, Westborough, MA, USA.
[24]
Oracle Corporation, Reading, UK.
[25]
Agilent Technologies, Santa Clara, CA, USA.
[26]
Hadassah Hebrew University Medical Center, Jerusalem, Israel.
[27]
King Hussein Cancer Center, Amman, Jordan.
[28]
Blue Cross Blue Shield Association, Chicago, IL, USA.
[29]
National Cancer Centre, Singapore.
[30]
New York University Langone Medical Center, NY, USA.
[31]
The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
[32]
Foundation Medicine Inc., Cambridge, MA, USA.
[33]
American Society of Clinical Oncology (ASCO), Alexandria, VA, USA.
[34]
UC San Diego - Moores Cancer Center, La Jolla, CA, USA.
[35]
主题词
成年人(Adult);老年人(Aged);老年人, 80以上(Aged, 80 and over);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);癌, 非小细胞肺(Carcinoma, Non-Small-Cell Lung);女(雌)性(Female);人类(Humans);肺肿瘤(Lung Neoplasms);男(雄)性(Male);中年人(Middle Aged);分子靶向治疗(Molecular Targeted Therapy)
DOI
10.18632/oncotarget.3741
PMID
25944621
发布时间
2020-05-02
- 浏览8
Oncotarget
Oncotarget
14139-52页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
